Cann American Corp (OTCMKTS: CNNA) has been on a steady rise over the past few weeks out of the low double zeroes to well over a penny. On Tuesday, CNNA tacked on another 12% on just under $1 million in dollar volume as the stock looks to take out 52-week highs of $0.149. Earlier this year CNNA made a change in management with the resignation of Jason Black who retained ownership of Cannequipt LLC as well as the loan agreements in “Cannagram” Canna Americen retained ownership and rights to the “C-Juice” lines of CBD and Delta 8 products as well as its hemp farming lease agreement in Glencoe, Oklahoma. Ambitious new CEO Jason Tucker quickly got to work entering the $12 billion global stem cell market with the acquisition of Prodigy Stem Cell. CNNA also acquired Liberty Health Plus; the nation’s first free pharmacy by providing 605 of the most prescribed generic medications for free through its membership plan. Prescriptions are accepted by 64,000 pharmacies nationwide.
According to CNNA director Pete Caruso this new opportunity for rapid expansion has increased revenue projections to be $10 million for 2023. CNNA CEO Jason Tucker is a wall street insider who got his last company to current reporting with the SEC after a decade of dormancy. He plans to quickly get CNNA on the OTCQB and the audit process is now down to final items such as verifying share structure with T/A. CNNA has filed all necessary documents and the filings are currently being formatted to the edgarized format. CNNA is quickly emerging as a volume leader on the OTC and has already attracted some major players on the bulletin boards. Still trading at a low market valuation of $3.9 million based on 401 million OS, the company is also renegotiating its notes in an effort to stop any further dilution. CNNA has a long history of big moves and it’s currently got momentum, rising liquidity and a fast-growing shareholder base on its side, a break over $0.149 52-week highs and CNNA could really take off. We will be updating on CNNA when more details emerge so make sure you are subscribed to newsytrends.com by entering your email below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Cann American Corp (OTCMKTS: CNNA) is a holding company building a diverse portfolio of intellectual properties. Now a publicly traded company under symbol (CNNA), Cann American Corp., through its subsidiaries, has expanded its focus toward developing assets and technologies through strategic acquisitions nationally.
In March, Cann America entered the $12 billion global stem cell market with the acquisition of Prodigy Stem Cell, a Company founded by Pete Caruso who was named as a director of CNNA as part of the transaction. Prodigy plans to offer its product lines to Dr.’s, sports medicine facilities, plastic surgery centers, and similar health and wellness clinics nationwide. Prodigy has already began to recruit high profile athletes, who are also current clients, to promote the Prodigy brand. Prodigy intends to rapidly expand into several of its own Prodigy branded wellness centers at strategic locations throughout the US. The Company is currently planning to launch a new facility in Florida, in addition to its flagship New Jersey office, within the coming weeks. Prodigy locations will be strategically opened in regions that host major sporting facilities and professional athletic training camps as its target market.
In April Prodigy opened a new office in Orlando Florida that will primarily serve clients in the Orlando and Winter Park areas as part of the Company’s rapid growth strategy. In addition to major tourism, this region is also host to an extensive number of professional sports training facilities, spring training camps, as well as health and wellness centers, all of which represent Prodigy’s target market. Prodigy already has high profile clients that spend significant time training in the Winter Park region. Meetings are already being scheduled to showcase Prodigy’s Florida presence.
We've been busy. For those that missed it, we did put out a $CNNA press two days ago…https://t.co/jaWgrVmIAE
With regard to the audit process, we're told the filings are being formatted for what they call "Edgarized". Enjoy the long Holiday weekend, next week should be big.
— CNNA (@CNNA_OTC) May 26, 2023
To Find out the inside Scoop on CNNA Subscribe to newsytrends.com Right Now by entering your Email in the box below
$CNNA gapping over a penny should test the 52 week high 014-015 quickly
— i_like_bb_stock (@thommic) May 30, 2023
Over the next several weeks and months the Company intends to further expand Prodigy into several key regions nationwide. Initially Prodigy intends to partner with parties and facilities that will benefit from the Prodigy product line, then incrementally launching its own Prodigy branded wellness centers, region by region, prioritized by revenue generating performance. The Company believes central Florida represents the best demographic fit for Prodigy’s initial expansion efforts.
In May Cann American acquired Liberty Health Plus (https://www.libertyhealthplus.com) the nation’s first free pharmacy by providing 605 of the most prescribed generic medications for free through its membership plan. Prescriptions are accepted by 64,000 pharmacies nationwide. Including: Walgreens®, CVS pharmacy®, Walmart Pharmacy®, Rite Aid®, and Albertsons®. Similar to a gym membership, once enrolled, customers get access to all Liberty Health Plus RX medications for free. Liberty Health Plus RX is a direct competitor to companies such as Mark Cuban’s Cost Plus Drugs. Whereas other programs charge a discounted generic drug fee, which can vary based on the type of medicine, the Liberty Health Plus RX membership fee, which covers your entire household, is all that customers will ever pay for access to generic prescriptions. As part of the transaction Michael Kramer was added to Cann Americans Board of Directors. The Company plans to re-brand Liberty Health Plus to Prodigy Health Plus and Prodigy Health Plus RX.
Cann American also recently hired Dr. Jason Schottel to act as a consultant to its subsidiaries and provide guidance on assisting Prodigy Health Plus patients gain access to regenerative therapies provided through Prodigy Stem Cell. Dr. Jason will also advise the Company on launching its planned wellness centers and speaking at Prodigy sponsored seminars. Cann American Director, Pete Caruso stated: “Once re-branded as Prodigy Health Plus, we look forward to offering Prodigy Stem Cell’s regenerative medicine treatments to patients nationwide through the Prodigy Health Plus network. I’m also very excited to have Dr. Jason’s expertise available to the Company. He is among the best in regenerative medicine and his established presence in Florida, through his clinics, will allow Prodigy Stem Cell to accelerate its availability to that market faster than previously anticipated. This new opportunity for rapid expansion has increased our revenue projections to be $10 million for 2023.”
$CNNA Former UFC Welterweight champion Nick Diaz gets stem cell treatments with Prodigy through CNNA ! Very bullish. he has close to 2 million instagram followers! This will be big! pic.twitter.com/7B4wk5dTyX
— Tellyomomtolick (@Tellyomomtolic2) May 30, 2023
We have something big Coming!
Cann American CEO, Jason Tucker: “Within the next few weeks, we will be revealing several significant updates that the Company has withheld during the completion of the lengthy audit process.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: we hold no position in CNNA either long or short and we have not been compensated for this article.